Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a trial.
Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...
The world’s oldest known geological map is a nine-foot-long papyrus from the Egyptian village of Deir el-Medina, home to the New Kingdom craftsmen who worked in the Valley of the Kings. Created by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback